Cardiac Psychiatry:  Clinical Care and New Directions

Jeffrey Huffman, M.D.

Introduction

Dr. Huffman is an Associate Professor of Psychiatry at Harvard Medical School and the Director of the Cardiac Psychiatry Research Program in the MGH Division of Psychiatry and Medicine. As the director of the program, he serves as principal investigator for over 10 studies spanning psychiatry, psychology, health behavior, and cardiovascular disease, including studies funded by NIH, the American Diabetes Association, and the American Heart Association, with 2 current R01s and an R21. Members and trainees of the program have included cardiologists, diabetologists, eight research fellows, psychologist post-doctoral fellows, junior staff psychiatrists, senior psychiatry residents, research social workers, and Harvard medical students; he received the Outstanding Research Mentor award in the MGH Psychiatry Department in 2016. In his work at the interface of psychiatry and cardiology, Dr. Huffman has given Grand Rounds at sites nationwide, presented research at national and international meetings, and published over 130 articles in peer-reviewed journals with over 100 first- or senior-author publications.  He also serves as the Associate Chief for Clinical Services in the Department of Psychiatry at MGH and the Director of Inpatient Psychiatry Research at MGH. This inpatient research has focused on assessment and treatments related to suicide risk in acutely ill psychiatric patients.

Learning Objectives

1. Outline the prevalence of depression among patients with acute and chronic heart disease.
2. Describe effective and safe treatments for depression and anxiety disorders in patients with heart disease.

Live webcast available at: http://videos.mayo.edu/live
1 AMA PRA Category 1 Credit(s)™ hour is offered for watching this Webcast live. Ethos will be implemented for all post presentation surveys. To document your attendance, please text the code given at the presentation to 507-200-3010. For questions, email rstpsychgr@mayo.edu.

Accreditation Statement

In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Statement(s)

AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

APA
The Department of Psychiatry and Psychology at Mayo Clinic, Rochester, is approved by the American Psychological Association to sponsor continuing education credits for psychologists. The Department of Psychiatry and Psychology at Mayo Clinic, Rochester maintains responsibility for this program and its content.

Archived webcast available at: Psychiatry & Psychology Video Library

Industry Acknowledgment (if applicable): None.

All participants MUST complete the evaluation in order to get CME or APA Credit.

1) Text the CODE announced at the session within 48 hours to (507) 200-3010
2) Login at ce.mayo.edu and go to My Account, My Courses, Registered Courses, click Session title and START to access the required Evaluation.
-or-
Click the START button on that session page.
3) Evaluation must be completed within 2 weeks.

Disclosure Summary
As a provider accredited by Joint Accreditation Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science (Mayo Clinic School of CPD) must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course Director(s), Planning Committee Members, Faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty also will disclose any off label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. Disclosure of these relevant financial relationships will be published in activity materials so those participants in the activity may formulate their own judgments regarding the presentation.
 

Listed below are individuals with control of the content of this program who have disclosed…

Relevant financial relationship(s) with industry:

Mark Frye, M.D. - Mayo Clinic

Grant Support: AssureRx, Janssen R&D, Myriad, Pfizer Consultant: Janssen R&D, Mitsubishi Tanabe Pharma Corp., Myriad Genetics, Sunovion, Supernus Pharmaceuticals, Teva Pharmaceuticals, Neuralstem, Inc.

CME/Travel: American Physician Institute, CME Outfitters

Speaker:  Jeffrey Huffman, M.D.

Grant Support:  NHLBI

Honoraria:  American Physician Institute (non-pharma CME)

No relevant financial relationship(s) with industry:
Kriti Gandhi, M.D., Allison Holgerson, Ph.D., Matej Markota, M.D., Charlene Nelson, Reem Shafi, M.B.B.S., Larua Suarez, M.D.

References to off-label usage(s) of pharmaceuticals or instruments in their presentation:

NONE